Cancer Research

How Does Penn Medicine Transform Cancer Treatment with CAR T Therapy?
Research & Development How Does Penn Medicine Transform Cancer Treatment with CAR T Therapy?

Penn Medicine’s Center for Cellular Immunotherapies (CCI) is at the forefront of revolutionizing cancer treatment through CAR (chimeric antigen receptor) T cell therapy. This innovative approach harnesses the power of the patient’s own immune system to target and destroy cancer cells, offering new

Enhanced YOLOv5s Algorithm for Accurate Brain Tumor MRI Segmentation
Tech & Innovation Enhanced YOLOv5s Algorithm for Accurate Brain Tumor MRI Segmentation

The detection and segmentation of brain tumors in MRI images present a critical challenge in medical diagnostics, given their implications for patient treatment plans and outcomes. Despite advancements in imaging techniques and manual segmentation methodologies, the need for precise, automated

PSMA-PET Imaging Significantly Improves Staging for Prostate Cancer
Research & Development PSMA-PET Imaging Significantly Improves Staging for Prostate Cancer

Recent advancements in imaging technology have caused a significant shift in how high-risk nonmetastatic hormone-sensitive prostate cancer is staged. Conventional imaging techniques, which have long been the standard, might have significantly underestimated the extent of metastasis in these

NUS Pioneers Magnetic Fields to Enhance Chemotherapy for Breast Cancer
Research & Development NUS Pioneers Magnetic Fields to Enhance Chemotherapy for Breast Cancer

Researchers at the National University of Singapore (NUS) have developed an innovative method to enhance the effectiveness of chemotherapy while mitigating its adverse side effects. This novel approach employs brief, localized pulses of magnetic fields, which significantly increase the uptake of

Expanding CAR-T Cell Therapy Market: Future Trends and Innovations
Research & Development Expanding CAR-T Cell Therapy Market: Future Trends and Innovations

CAR-T cell therapy has emerged as a groundbreaking approach in cancer treatment, leveraging the body's immune system to target and destroy cancer cells. Since its inception in 2017, this innovative therapy has rapidly evolved, with numerous products reaching commercialization and receiving

Can Topical Immunotherapy Reduce Precancerous Skin Lesions and SCC Risk?
Research & Development Can Topical Immunotherapy Reduce Precancerous Skin Lesions and SCC Risk?

The rise in skin cancer cases worldwide has necessitated the exploration of innovative and more efficient treatments. Among the promising solutions is immunotherapy for cancer, a revolutionary method known for its effectiveness. However, this approach is often expensive and may cause severe side

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later